retatrutide clinical trial status retatrutide Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide vs Ozempic: Clinical Trial

On April 30, 2026, the FDA proposed to formally exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List, citing no clinical need for outsourcing facilities to compound these drugs from bulk substances

Three hemodialysis sessions over 48 hours brought the lithium level down to 0.3 mEq/L and creatinine returned to baseline

Serious Allergic Reactions: Stop using Wegovy right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy

An Analytical Study Based on Post-Marketing Approval Pharmacovigilance Data

Some regions offer structured lifestyle intervention programs modeled on the Diabetes Prevention Program research that demonstrated 58% reduction in diabetes incidence through diet and exercise

Roughly 25% of the company's sales comes from food